• An Investigation Into Open-Source Modelling In Health Economics- Opportunities And Challenges

    Nov 1, 2016, 00:00

  • Opportunities For Pharmaceutical Companies To Successfully Launch Products In African Countries

    Nov 1, 2016, 00:00

  • Methods For The Design And Conduct Of Medical Record Reviews In Oncology

    Nov 1, 2016, 00:00

  • Rosuvastatin- Switching Treatment and Clinical Implications in Primary Care

    Nov 1, 2016, 00:00

  • Cost Analysis of Intrathecal Baclofen Therapy For The Treatment of Spastic Cerebral Palsy In The Russian Federation

    Nov 1, 2016, 00:00

  • Cyproterone/Ethinylestradiol Use and Indications in the Netherlands

    Nov 1, 2016, 00:00

  • Recommendations In Clinical Guidelines, ‘No Benefit’ Ratings, And Opt-Out Decisions In Germany Since The Introduction Of The Amnog Law In 2011- How Do The Pieces Fit Together?

    Nov 1, 2016, 00:00

  • Economic Burden of Colorectal Resections- Incremental Effects in Cancer Patients

    Nov 1, 2016, 00:00

  • Economic Evaluation of Tiotropium/Olodaterol Administrated Through The Respimat Inhaler As Maintenance Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) In Poland

    Nov 1, 2016, 00:00

  • Changes In The Capacity Of Neurological And Psychiatric Inpatient Care In Hungary Between 1990 And 2014

    Nov 1, 2016, 00:00

  • Risk of Cardiovascuar Disease in Type 2 Diabetic Women on Sulfonylureas-A Retrospective Case-Control Study

    Nov 1, 2016, 00:00

  • Economic Evaluation of ASA 100mg, Simvastatin 40mg and Ramipril 5-10mg (POLYPILL) for Secondary Prevention of Cardiovascular Events in Mexico

    Nov 1, 2016, 00:00

  • A Comparison of Long-Term Anticholinergic Burden Derived from Different Risk Scales with Adverse Clinical Outcomes in the Elderly

    Nov 1, 2016, 00:00

  • The Association Between Initiation of Guideline Recommended First-Line Systemic Therapy and Healthcare Costs and Utilization in a Metastatic Non-Small Cell Lung Cancer (MNSCLC ) Population

    Nov 1, 2016, 00:00

  • Current Practice of Drug Treatment In Children with ILD- First Insights From The Child-Eu Registry

    Nov 1, 2016, 00:00

  • A Comparative Analysis on Health Security System Between China and Developed Countries

    Nov 1, 2016, 00:00

  • what Do we Pay for Compounded Drugs?

    Nov 1, 2016, 00:00

  • Health Technology Assessments of Lama/Laba Combination Products

    Nov 1, 2016, 00:00

  • A Cost-Effectiveness Analysis of Biosimilar Infliximab (Inflectra®) For The Treatment of Psoriatic Arthritis In Nine European Countries

    Nov 1, 2016, 00:00

  • The Cost of Remaining NTM Positive- Health Care Utilization and Costs In A Sample of Patients with Refractory Pulmonary Disease Due To Mycobacterium Avium Complex In Canada, Germany, United Kingdom And France

    Nov 1, 2016, 00:00

  • One-Year Patient-Reported Persistence To Antiresorptive Treatment In A Fracture Liaison Servi The Lucky Bone™ Program

    Nov 1, 2016, 00:00

  • Application of Risk Adjusted Cost-Effectiveness Analyses for Stroke Treatment

    Nov 1, 2016, 00:00

  • Comparison Study Based on Simulation of Patient Pathways Using Multi-State Models in Oncology

    Nov 1, 2016, 00:00

  • The Effect of Diabetes on the Quality-of-Life in Community-Dwelling Elderly in The Netherlands

    Nov 1, 2016, 00:00

  • Development and Content Validity of the Advanced Systemic Mastocytosis Symptom Assessment Form (ADVSM-SAF)

    Nov 1, 2016, 00:00

  • The Economic Burden of Non-Tuberculous Mycobacterial Pulmonary Disease In Canada, France, United Kingdom And Germany

    Nov 1, 2016, 00:00

  • Accuracy Of Natural Language Processing-Based Classifiers For Automated Identification Of Abstracts Of Studies On Humanistic And Economic Burden Of Disease

    Nov 1, 2016, 00:00

  • The Burden of Inflammatory Bowel Disease(IBD) in Japan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Transfemoral Aortic Valve Implantation Compared with Surgical Aortic Valve and Medical Management in Patients with Severe Symptomatic Aortic Stenosis in Australia

    Nov 1, 2016, 00:00

  • Community Residents' Knowledge and Perceptions of Antibiotic Resistance in Penang, Malaysia- Findings and Implications

    Nov 1, 2016, 00:00

  • Understanding Racial And Ethnic Differences In End of Life Care For Hospitalized Patients

    Nov 1, 2016, 00:00

  • Predicting Patient-Reported Outcomes from Disease-Specific Questionnaires- A Comparison of Seven Methodologies

    Nov 1, 2016, 00:00

  • All-Cause Mortality and Cardiovascular Events After Acute Myocardial Infarction and 12-Months Dual Platelet-Aggregation Inhibition in Clinical Practice. Findings from the Piper Study

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Dexamethasone Intravitreal Implant for Treatment of Diabetic Macular Oedema in Spain

    Nov 1, 2016, 00:00

  • An Exploration of Techniques for Addressing Uncertainty in Survival Estimates used Within Partitioned-Survival Models

    Nov 1, 2016, 00:00

  • Italian Timings In New Drugs Approval- An Up-To-Date Analysis

    Nov 1, 2016, 00:00

  • Defining Episodes of Care for Chronic Diseases- A Targeted Literature Review

    Nov 1, 2016, 00:00

  • Indirect Cost Of Hiv/Aids- Results Of A Survey From A Turkish Research Center

    Nov 1, 2016, 00:00

  • Clinical And Economic Analysis Of Two Surfactants For The Prevention And Treatment Of Respiratory Distress Syndrome

    Nov 1, 2016, 00:00

  • Dose Escalation of Biologics in Crohn’s Disease- Summary of Observational Studies in the UK

    Nov 1, 2016, 00:00

  • Economic and Humanistic Benefits of Maintaining Cognitive Impairment Patients in the Early Stage

    Nov 1, 2016, 00:00

  • Longitudinal Trend of Human Immunodeficiency Virus (HIV) Prevalence Rates in the United States

    Nov 1, 2016, 00:00

  • A CPRD-HES Database Study of Back Pain In The UK- Incidence And Prevalence

    Nov 1, 2016, 00:00

  • Economic Evaluation Guideline for Pharmaceuticals and Medical Devices in Japan

    Nov 1, 2016, 00:00

  • General Practitioners Perceptions About Financial and Non-Financial Incentives to Improve Influenza Vaccination Coverage Rates In France

    Nov 1, 2016, 00:00

  • Advanced Renal Cell Carcinoma in Previously Treated Patients- Measuring Healthcare Use, Productivity Loss and Costs

    Nov 1, 2016, 00:00

  • Preliminary Evaluation Of “Introducing Immigrants To The Healthcare System In Chile” Pilot Programme

    Nov 1, 2016, 00:00

  • Long-Term Improvements in Workplace and Household Productivity and Social Participation Over 4 Years of Certolizumab Pegol Treatment in Patients with Psoriatic Arthritis, with and without Prior Anti-Tnf Exposure

    Nov 1, 2016, 00:00

  • How Are Fast-Track Programmes Like Rapid Recovery Delivering Value Across Hospitals, Cultures And Healthcare Systems In Orthopedics Within A Cost-Constrained Environment?

    Nov 1, 2016, 00:00

  • Nice’s Criteria for End-Of-Life Therapies- Is there a Fourth Hurdle to Overcome?

    Nov 1, 2016, 00:00

  • Implications of Introducing Patient Heterogeneity in Cost Effectiveness Modeling

    Nov 1, 2016, 00:00

  • The Benefits of A Holistic View- Considering Multiple Health Outcomes for Hiv and Sti Testing

    Nov 1, 2016, 00:00

  • How To Select The Best Comparator? An International Economic Evaluation Guidelines Comparison

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Early Tips with Expanded Polytetrafluoroethylene (EPTFE) Covered Stent-Grafts Compared to Endoscopic Procedures to Manage Acute Variceal Bleeding – A Spanish Scenario

    Nov 1, 2016, 00:00

  • Situation and Impact of Insulin Pen Needle Reuse for Patients with Diabetes in China

    Nov 1, 2016, 00:00

  • Upcoming Regulations on Insurance Reimbursement Standard in China- Chanllanges and Opportunites for Mncs

    Nov 1, 2016, 00:00

  • Dexhelpp - Aging Population- Routine Data Based Analyses Of Fractures Due To Falls Less Than Three Meters – Hospitalization, Readmission And Mortality

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Teriflunomide Used For Multiple Sclerosis Patients In Russia

    Nov 1, 2016, 00:00

  • Universal Health Coverage in Countries Across East and Southeast Asia – Associations Between Health Expenditure and Service Provision

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Diagnostic Tests for People At Risk of Non-Alcoholic Fatty Liver Disease (NAFLD) in The UK

    Nov 1, 2016, 00:00

  • The Effectiveness Analysis of Selected Radiosurgery Devices on Treatment of Cancer Tumors and Arteriovenous Malformations- A Systematic Review

    Nov 1, 2016, 00:00

  • Unspecified Intestinal Malabsorption Associated with Angiotensin Receptor Blocker Therapy- Results from a Nationwide, Population-Based Study in Italy and Germany

    Nov 1, 2016, 00:00

  • Bayesian Network of Disease History

    Nov 1, 2016, 00:00

  • Type 2 Diabetes- How Much Does it Cost During the First 8 Years after the First Antidiabetic Treatment? A Dynamic Approach from the French National Health Insurance

    Nov 1, 2016, 00:00

  • Imatinib Discontinuation and Tki Switching Patterns in the Retrospective and Prospective Cohorts in Simplicity, A Study of Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients (PTS) in Routine Clinical Practice

    Nov 1, 2016, 00:00

  • Subclinical Hypothyroidism In Pediatric Population Treated With L-Thyroxine- A Retrospective Observational Analysis on 2001–2014 Administrative Data

    Nov 1, 2016, 00:00

  • The Association Between Disability And Early Exit From Work In Osteoarthritis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of A Potential Treatment Introduction for Anorexia-Cachexia in Non-Small Cell Lung Cancer Patients

    Nov 1, 2016, 00:00

  • The Effect of Therapeutic Drug Monitoring in Patients Complian An Improvement in Drug Efficacy and Corresponding Reduction in Toxicity Using Aminoglycosides

    Nov 1, 2016, 00:00

  • Retrospective Survey For Hepatitis B Virus Reactivation During Immunosuppressive Therapies For Rheumatoid With Administrative Data

    Nov 1, 2016, 00:00

  • Quinolones Utilization In Two Tertiary Hospitals In Nigeria; Exploring Drug Use Towards Improved Treatment Outcomes

    Nov 1, 2016, 00:00

  • Societal Impact of Pain (SIP) 2016 - 8 Policy Recommendations- Time for Action

    Nov 1, 2016, 00:00

  • The Determinants Of Innovative Drugs Prices- The Case Of Oncology Drugs, Comparative Analysis

    Nov 1, 2016, 00:00

  • What do HTAS Look Like Around the World? A Comparison of South Korean and British HTA Agencies

    Nov 1, 2016, 00:00

  • Pharmaceutical Tracking System- An Improvement in Data Accuracy and Uses

    Nov 1, 2016, 00:00

  • Time To Formal ‎Reimbursability ‎For Innovative ‎Drugs In Italy ‎

    Nov 1, 2016, 00:00

  • Treatment Satisfaction Of Osteoporosis Medication In Postmenopausal Women Of Korea; Results From The Study Of Osteoporosis Medication Adherence And Satisfaction In Postmenopausal Women

    Nov 1, 2016, 00:00

  • Estimated Range of Cost of Treatment of Adult Schizophrenia Patients at a Tertiary Hospital as of October 2015

    Nov 1, 2016, 00:00

  • Investigation Of The Work Ability Of Nurses And Its Influencing Factors

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis Of Highly Innovative Treatments For Hepatitis C- The Case Of Ledipasvir/Sofosbuvir In A Greek Healthcare Setting

    Nov 1, 2016, 00:00

  • Diagnostic Accuracy of Assessment Methods for Diagnosing Diabetic Peripheral Neuropathy (DPN)- A Systematic Review and Meta-Analysis- An Evidence Based Approach

    Nov 1, 2016, 00:00

  • Too Old for Treatment- Ageism in Chronic Lymphocytic Leukemia (CLL). A Narrative review of the Literature

    Nov 1, 2016, 00:00

  • Comparing Eq-5d-3l And Eq-5d-5l In A General Population

    Nov 1, 2016, 00:00

  • Cost Effectiveness of Sacubitril/Valsartan Versus Angiotensin-Converting-Enzyme Inhibitor For The Treatment of Heart Failure From Public Health Perspective in Chile

    Nov 1, 2016, 00:00

  • Complementary and Alternative Medicine use and Its Association with Quality of Life Among Cancer Patients Receiving Chemotherapy in Ethiopia- A Cross Sectional Study

    Nov 1, 2016, 00:00

  • Potential Efficacy of Lomitapide, A MTP (Microsomal Triglyceride Transfer Protein) Inhibitor, on Survival in Homozygous Familial Hypercholesterolaemia (HOFH)- Results of an Event Modelling Analysis

    Nov 1, 2016, 00:00

  • Comparing Costs from a Pragmatic Randomised Trial to Published Modelling-Based Estimates- An Example from Prostate-Cancer Screening

    Nov 1, 2016, 00:00

  • Treatment Patterns of Relapsed and Refractory Multiple Myeloma in Europe (EU-28)

    Nov 1, 2016, 00:00

  • Using Clinical Trial and Real World Data to Bridge Efficacy to Effectiveness of Fingolimod in Multiple Sclerosis Patients

    Nov 1, 2016, 00:00

  • Effect of Spironolactone on The Risk of New Onset of Diabetes Among Patients with Heart Failure- A Population-Based Study

    Nov 1, 2016, 00:00

  • Effect of Drug Cost-Sharing Change on Non-Adherence to Essential Medications for Acute Coronary Syndrome- A Population Based Natural Experiment

    Nov 1, 2016, 00:00

  • Analysing the Prescribing Landscape for Oral Anticoagulants

    Nov 1, 2016, 00:00

  • Dose Extension and Costs of Lanreotide Autogel 120 Mg Used in Routine Neuroendocrine Tumors Care In Poland – 2- Years Data From Lanro-Net Study

    Nov 1, 2016, 00:00

  • Analysis of Orphan Drugs Reimbursement in Major European HTA Agencies

    Nov 1, 2016, 00:00

  • German Travelers’ Preferencences For Vaccines Against Travel-Related Illnesses

    Nov 1, 2016, 00:00

  • Childhood Stunting, Wasting and Obesity in Indonesia- Evidence from the Indonesian Family Life Survey

    Nov 1, 2016, 00:00

  • Knowledge And Participation Rate on Cervical Cancer Screening Among Romany Minority Population

    Nov 1, 2016, 00:00

  • Methodology of Research to Determine Cost and Utility of Pilot One-Stop Fertility Clinic Versus Traditional NHS Fertility Investigation Pathway

    Nov 1, 2016, 00:00

  • Towards Better Coordination and More Efficient Patient Pathways in Copd

    Nov 1, 2016, 00:00

  • Combining A Real-World Observational Study And A Network Meta-Analysis of Randomised Controlled Trials To Determine Relative Treatment Effects In Type 2 Diabetes

    Nov 1, 2016, 00:00

  • Actuarial Approaches To Modelling and Mitigating Financial Uncertainty in Recommending New Drugs and Health Technologies

    Nov 1, 2016, 00:00

  • 5 Year and Long-Term Budget Impact Analysis of New Hepatitis C Therapies from A Payer Perspective in Switzerland

    Nov 1, 2016, 00:00

  • Retrospecive Patient Chart Study to Evaluate Real Life Treatment and Event Rate of Patients Surviving Their Myocardial Infarction for at Least 12 Months

    Nov 1, 2016, 00:00

  • Efficacy and Safety of Azathioprine for Multiple Sclerosis- A Rapid Review

    Nov 1, 2016, 00:00

  • Health-Economic Analysis of The Use of Sensor-Augmented Pump with Predictive Suspend Function (SAP) Therapy in Sweden Compared to Insulin Pump Therapy Alone (CSII), in Type 1 Diabetic Patients

    Nov 1, 2016, 00:00

  • Sick Leave and Disability Pension in Patients with Chronic Hepatitis C Compared with Matched General Population Comparators- A Nationwide Population-Based Register Study

    Nov 1, 2016, 00:00

  • Effect Of A Pay-For-Performance Program For Diabetes On Health Status (Eq-5d) In Taiwan

    Nov 1, 2016, 00:00

  • How can healthcare pathways explain polypharmacy in france? A longitudinal analysis between 2011 and 2014

    Nov 1, 2016, 00:00

  • Quality of Life of Stroke Survivors and Their Informal Caregivers- A Prospective Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Saxagliptin Versus Acarbose as Second-Line Therapy in Type 2 Diabetes in China

    Nov 1, 2016, 00:00

  • ASSESSMENT OF PET/CT USE IN RADIOTHERAPY PLANNING VERSUS CT SCANS USE ONLY

    Nov 1, 2016, 00:00

  • Increasing Trend Of Health Related Quality Of Life Awareness For Diabetic Care Among Indian Scientists

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Dapagliflozin Versus Glimepiride as Monotherapy in Patients with Type 2 Diabetes Mellitus in China

    Nov 1, 2016, 00:00

  • Indirect Costs Genereted by Absenteeism Associated with Insulin Dependent Diabetes Mellitus (IDDM) in Poland

    Nov 1, 2016, 00:00

  • Prompt Value Assessment Of Breakthrough Interventions With Limited Outcome Data

    Nov 1, 2016, 00:00

  • Herpes Zoster And Postherpetic Neuralgia- Quality Of Life And Healthcare Utilization, A German Study

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of Rivaroxaban For Treatment of Deep Vein Thrombosis And Pulmonary Embolism In Greece

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Brentuximab Vedotin in Adults with Relapsed or Refractory Hodgkin’s Lymphoma

    Nov 1, 2016, 00:00

  • Lost in Translation- Randomised Controlled Trial and Systematic Review Evidence of Intracoronary Versus Intravenous Abciximab in St-Elevation Myocardial Infarction

    Nov 1, 2016, 00:00

  • Relationship between Insulin Adherence and Health Care Resource Utilization among Type 2 Diabetes Patients in China

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Laparoscopic and Open Surgery for Rectal Cancer

    Nov 1, 2016, 00:00

  • Acute Cardiovascular Adverse Reaction of Cox-2 Inhibitors Among Osteroarthritis Patients in Taiwan

    Nov 1, 2016, 00:00

  • Quality of Life Measured with Eq-5d in Patients with Major Depressive Disorder in Japan

    Nov 1, 2016, 00:00

  • Good Enough For Policy Work? Study-Design Challenges In Implementing Stated-Preference Methods For Complex Health-Care Technologies

    Nov 1, 2016, 00:00

  • Assessment of Knowledge of Urinary Tract Infection (UTI) Amongst School-Going Adolescent Girls

    Nov 1, 2016, 00:00

  • Effect Of Sociodemographic Determinants And Socio-Economic Status On Poliomyelitis Immunization Among Under-Five Children In Pakistan

    Nov 1, 2016, 00:00

  • Factors Associated with The Mental and Physical Health-Related Quality of Life (HRQOL) of Asthma Patients- A Cross-Sectional Analysis Based On 673 Patients

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Fingolimod Vs Brace Cycling Followed By A Switch To Fingolimod In Patients Failing Prior Treatment

    Nov 1, 2016, 00:00

  • The Evaluation of Relationship between Regular Inspection and Committing Major Malpractice in Pakdasht Pharmacies

    Nov 1, 2016, 00:00

  • Understanding The Role of Dermatologists And Oncologists In Melanoma Treatment In France and The UK

    Nov 1, 2016, 00:00

  • Real Time Patient Reported Outcomes Assessment in Routine Rheumatology Clinic - Feasibility Study of Myra Touch

    Nov 1, 2016, 00:00

  • Lenalidomide for Treating Multiple Myeloma After 1 Prior Treatment; An Application of Multi-State Markov Modelling for the Extrapolation of Patient Level Survival Data

    Nov 1, 2016, 00:00

  • Similarities and Differences of Risk Sharing Arrangements in Australia, United Kingdom, Italy, and Korea

    Nov 1, 2016, 00:00

  • The Direct Cost Components in Heart Failure with Reduced Ejection Fraction (HF-REF) in Turkey- The Results of A Delphi Panel

    Nov 1, 2016, 00:00

  • Assessment of Utility for Heart Failure using Visual Analogue Scale(VAS), Time-Trade off(TTO) and Euroqol-5 Dimension(EQ-5D) in the Korean General Population

    Nov 1, 2016, 00:00

  • The Economic Burden of Heart Failure in Greece From A Social Security System Perspective

    Nov 1, 2016, 00:00

  • A Proposed Holistic Conceptual Framework for Barriers to Medication Adherence in Diabetes

    Nov 1, 2016, 00:00

  • A General Model for The Estimation of Societal Costs of Lost Production and Informal Care In Italy

    Nov 1, 2016, 00:00

  • Evaliation of Utility Index of Quality of Life In Hepatitis Patients in Japan

    Nov 1, 2016, 00:00

  • Budget Impact Analysis of Xydalba from the Perspective of Italian National Health System

    Nov 1, 2016, 00:00

  • A Cost Per Responder Analysis of Secukinumab Vs Adalimumab Based on A Matching-Adjusted Indirect Comparison For The Treatment of Ankylosing Spondylitis From A German Payer Perspective

    Nov 1, 2016, 00:00

  • Effects of Opioid use with and without Over-The-Counter Analgesics on Economic Outcomes Among Adults with Pain in the United States

    Nov 1, 2016, 00:00

  • Comparative Analysis of Clinical Trial Attributes in Pivotal Studies for Orphan vs. Non-Orphan Oncology Products FDA-Approved between 2011 and 2015

    Nov 1, 2016, 00:00

  • Methods for Time-Varying Exposure – A Literature Review

    Nov 1, 2016, 00:00

  • Cost-Sharing In Healthcare- An Approach For Pharmaceutical Care In Greece

    Nov 1, 2016, 00:00

  • Reducing Medical Claims Cost to Ghana’s National Health Insurance Scheme- Paper-Based Versus Electronic-Based Claims Review

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes in Greece

    Nov 1, 2016, 00:00

  • Measuring Income-Related Inequity In Self-Assessed Health Using The EQ-5D In 7 Countries

    Nov 1, 2016, 00:00

  • A Value for Money Threshold for New Technologies for Very Rare Diseases- Does the Nice Highly Specialised Committee Employ One?

    Nov 1, 2016, 00:00

  • Evaluation of The Cost Saving Potential of Introducing An Etanercept Biosimilar (Benepali®) For The Treatment of All Licensed Adult Etanercept Indications In The UK

    Nov 1, 2016, 00:00

  • Personalized Adaptive Rewards Versus Incentives to Motivate Sustainable Healthy Behavioral Change- A Neo-Maslowian Conceptual Model

    Nov 1, 2016, 00:00

  • Identifying the Key Parameters of the European-Study on Quantifying Utility of Investment in Protection from Tobacco (EQUIPT) Model

    Nov 1, 2016, 00:00

  • Alemtuzumab Budget Impact For Multiple Sclerosis Treatment In Spain

    Nov 1, 2016, 00:00

  • Economic Analysis of Endovascular Interventions for The Treatment of Femoropopliteal Peripheral Artery Disease in Austria

    Nov 1, 2016, 00:00

  • Discordance Between Knowledge of Cardiovascular Risk Factors and Ideal Cardiovascular Health in Hong Kong Adults

    Nov 1, 2016, 00:00

  • Innovative Approach To Keeping Evidence Current And Guidelines Living

    Nov 1, 2016, 00:00

  • Budget Impact Model Of Indacaterol/Glycopyrronium In The Treatment Of Copd In Italy Based On Flame Study

    Nov 1, 2016, 00:00

  • Investigating the Implementation of Adverse Events in Economic Models- A Systematic Literature Review in Multiple Sclerosis and Human Immunodeficiency Virus

    Nov 1, 2016, 00:00

  • Racial Differences in Cardiovascular Disease in The United States- Healthcare Resource Utilization and Costs

    Nov 1, 2016, 00:00

  • Incorporating Biometric Data from Wearable Activity Trackers with Study Data in France and the UK

    Nov 1, 2016, 00:00

  • Use of Nimotuzumab in The Treatment of Locally Advanced Esophageal Cancer in Real World

    Nov 1, 2016, 00:00

  • Differences in Cost-Effectiveness Estimates for Chronic Hepatitis C Treatment Among Cohort Markov Model, Markov Microsimulation and Discrete Event Simulation

    Nov 1, 2016, 00:00

  • The Epidemiology and Cardiovascular Disease Risk Assessment of Patients Currently on Lipid Lowering Treatment with Statin- Nationwide Cross-Sectional Study in Korea

    Nov 1, 2016, 00:00

  • Comparison Between Cancer Drugs Assessment In Portugal And United Kingdom

    Nov 1, 2016, 00:00

  • What is Government's Responsibility for China's Universal Health Security? An Outlook for a National Health Security System

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Crizotinib Among ALK+ NSCLC Patients Across The United States, Western Europe, and Japan

    Nov 1, 2016, 00:00

  • The Direct Cost-Components in Pulmonary Arterial Hypertension- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2016, 00:00

  • How time and severity increases the overall cost and resource utilization of patient with severe liver disease. Main burdens and consequences to health system

    Nov 1, 2016, 00:00

  • Cost Analysis of Different Sequential Treatment Regimens for Metastatic Renal Cell Carcinoma in China

    Nov 1, 2016, 00:00

  • Systematic Review and Meta-Analysis of Risperidone for the Treatment of Schizophrenia

    Nov 1, 2016, 00:00

  • Economic Burden of Hospitalization for Hepatic Encephalopathy in Fran An Analysis of Cost Discriminating Factors By Patient Profile

    Nov 1, 2016, 00:00

  • Health Technology Assessment In Brazil- Metrics From The Reports Of The National Commission For Incorporation Of Technologies (Conitec)

    Nov 1, 2016, 00:00

  • Mcda Application In Central And Eastern Europe- Selection Of The Most Important Criteria Based On Examples

    Nov 1, 2016, 00:00

  • Cost-Utility Evaluation of Insulin Glargine 300 (GLA-300) Versus Insulin Glargine 100 (GLA-100) in Patients with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2016, 00:00

  • Synthesis of Binary Outcome Data on the Log-Odds and Absolute Risk Scales – A Case Study in Chronic Hepatitis C

    Nov 1, 2016, 00:00

  • Investigation About Influence Of Management Strategy In National Hospital Organization (Nho) Hospitals By The Revision Of Medical Fee Schedule

    Nov 1, 2016, 00:00

  • Sampling of Commonly used Population Characteristics- Is A Normal Approximation Valid?

    Nov 1, 2016, 00:00

  • Systematic Review And Meta-Analysis of Accuracy of Diagnostic Tests For Screen Detection of Atrial Fibrillation

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Adding Bedaquiline To Background Drug Regimens For The Treatment of Multidrug-Resistant And Extensively-Resistant Tuberculosis In Italy

    Nov 1, 2016, 00:00

  • Value of Expanding Hcv Treatment Capacity in Germany Through Novel, Effective and Shorter Duration Therapies

    Nov 1, 2016, 00:00

  • Food for Thought (But Not Too Much) for Health Economic Analyes of Nutritional Interventions in Obesity

    Nov 1, 2016, 00:00

  • Big Data In Healthcare - Opportunities And Challenges

    Nov 1, 2016, 00:00

  • Burden of Non-Tuberculous Mycobacterial Pulmonary Disease In Germany Based on Sick Fund Data Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of A Bone Transplant Fixation “Shark Screw” Transplant Compared To Metal Devices In Oesteosynthesis In Austria

    Nov 1, 2016, 00:00

  • Implementation of Conditional Reimbursement Schemes in HTA Practi Experiences from the Netherlands

    Nov 1, 2016, 00:00

  • Analysis on the Utilization Status of Essential Medicines in Beijing's Community Health Institutions

    Nov 1, 2016, 00:00

  • Clinical Trials Scenario In Brazil- Study And Sponsor Profiles

    Nov 1, 2016, 00:00

  • Cost of Treatment of Pancreas Transplantation Therapy and Insulin Pump Therapy of Type I Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Health-Related Quality of Life In Patients with Systemic Lupus Erythematosus (SLE)- A Spanish Study Based on Patient Reports

    Nov 1, 2016, 00:00

  • Potential Factors Predicting The Response in The Treatment of Attention-Deficit/Hyperactivity Disorder Children with Atomoxetine in Asia Pacific Region

    Nov 1, 2016, 00:00

  • Comorbidites and Patient-Reported Outcome after Total Hip Arthroplasty

    Nov 1, 2016, 00:00

  • Clinical and Economic Analysis of Eyelid Hygiene Complex for Patients with Meibomian Glands Dysfunction in Russia

    Nov 1, 2016, 00:00

  • Three-Monthly Long-Acting Formulation of Paliperidone Palmitate is a Dominant Treatment Option, Cost Saving While Adding Qalys, Compared to the One-Monthly Formulation in the Treatment of Schizophrenia in France

    Nov 1, 2016, 00:00

  • Adverse Drug Reactions of Radiographic Contrast Media Used in Computed Tomography and Magnetic Resonance Imaging in India

    Nov 1, 2016, 00:00

  • Risk Elements and Drug Utilization in Stroke Patients

    Nov 1, 2016, 00:00

  • Comparisons of Treatment Patterns for Type 2 Diabetes Mellitus (T2DMm) in Japan and in the United States

    Nov 1, 2016, 00:00

  • Estimation of The Direct Cost of COPD In Bulgaria

    Nov 1, 2016, 00:00

  • The Quev Score- A Quantitative Evaluation of the Quality of Clinical Evidence in HTA

    Nov 1, 2016, 00:00

  • Outcomes for Older Patients with Acute Myeloid Leukemia (AML)- Multiple Hospitalizations and High Mortality Rates

    Nov 1, 2016, 00:00

  • Costs of Adverse Events Associated with Cancer Therapies in Non-Small Cell Lung Cancer in France

    Nov 1, 2016, 00:00

  • Patterns of Care Among Pancreatic Cancer Patients- Findings from a u.s. Real-world claims-based analysis

    Nov 1, 2016, 00:00

  • The Dynamics of Quality of Life In Children With Uncontrolled Severe Persistent Asthma

    Nov 1, 2016, 00:00

  • The Assessment of Value for Medical Devices- Using Real World Evidence (RWE) to Quantify Unmet Needs in Diabetes Management

    Nov 1, 2016, 00:00

  • The Management and Costs of Multiple Myeloma in Gree Mapping the Local Treatment Pathway and Associated Resource Use

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis of Generic Versus Brand Form of Deferasiroix N The Management of B-Thalassemia Patients with Chronic Iron Overload- An Egyptian Health Care Provider Perspective

    Nov 1, 2016, 00:00

  • Management of Metastatic Colorectal Cancer Patients- A Methodological Approach to Identify Treatment Lines

    Nov 1, 2016, 00:00

  • A Health Outcomes Model Showing Stroke Prevention in Atrial Fibrillation and Cost-Savings in England

    Nov 1, 2016, 00:00

  • External Validity at Stake in Mapping Non-Preference Based Disease Specific Measures to Generic Preference-Based Utility Values in Advanced Cutaneous Melanoma

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Neoadjuvant Chemotherapy with Pertuzumab, Trastuzumab and Docetaxel in Patients With HER2+ Breast Cancer in Spaincost-Utility Analysis of Neoadjuvant Chemotherapy with Pertuzumab, Trastuzumab and Docetaxel in Patien ...

    Nov 1, 2016, 00:00

  • Impact of Poverty on Health Care Utilization in the Elderly

    Nov 1, 2016, 00:00

  • The Influence Of Price Regulation Method On Price Trajectory – Assessment Of Cancer Drug Prices In Usa, The Uk And Israel

    Nov 1, 2016, 00:00

  • Integration Of Basic Attention To The Specialized Attention Network In Brazil’s Health System

    Nov 1, 2016, 00:00

  • The Apheresis- Database (APHDA)-Project- Patient Characteristics Treatment Patterns of Apheresis Patients in Germany

    Nov 1, 2016, 00:00

  • The Quality of Pharmacoeconomic Publications in Breast Cancer Pharmacotherapies in China

    Nov 1, 2016, 00:00

  • Evaluation Of The Impact Of Pharmacists Qualification And Years Of Practice On Pharmaceutical Care Services In Community Pharmacy Practice In Enugu Nigeria

    Nov 1, 2016, 00:00

  • Assessing Real Consumption of Medications for Fertility Treatments in Ukraine

    Nov 1, 2016, 00:00

  • The Structure and Vascularization of Choroid Plexus of Brain in Children Aged From 0–3 Years Old

    Nov 1, 2016, 00:00

  • Regulatory Agencies Perspective on Progression-Free-Survival (PFS)

    Nov 1, 2016, 00:00

  • Impact of Medication Therapy Management Service Provided by Clinical Pharmacists on Drug Therapy of Patients Undergoing Hemodialysis

    Nov 1, 2016, 00:00

  • Cost Minimization Of 10% Intravenous Immunoglobulin Against Other Intravenous Immunoglobulin For Treating Primary Inmunodeficiencies

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Newer Antiepileptic Drugs (Aeds) For Management of Partial Epilepsy In Children In Malaysia

    Nov 1, 2016, 00:00

  • The Societal and Humanistic Burden of Small Cell Lung Cancer (SCLC)- A Systematic Review of Societal Impact and Health-Related Quality Of Life (HRQOL) Literature

    Nov 1, 2016, 00:00

  • A Budget Impact Analysis To Estimate The Cost Savings from Alectinib on Patients With Anaplastic Lymphoma Kinase (ALK) Positive Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (NSCLC) Previously Treated with Crizotinib

    Nov 1, 2016, 00:00

  • Cost Effectiveness Evaluation of Fracture Liaison Services for the Management of Osteoporosis in Sweden

    Nov 1, 2016, 00:00

  • Direct Healthcare Costs and Clinical Outcomes of Open Abdominal Aortic Aneurysm Repair in Spain. Recapta Study

    Nov 1, 2016, 00:00

  • Extrapolation with Patient Level Time-To-Event Data in Various Disease Areas- A Review of Current Recommendations and Gaps

    Nov 1, 2016, 00:00

  • Icpc-2 Episode-Based Health-Related Quality Of Life And Three Months Effectiveness In Three Finnish Primary Health Care Settings

    Nov 1, 2016, 00:00

  • A Cohort Study to Access the Impact of Paediatric Use of Proton Pomp Inhibitor on the Risk of Community Acquired Infections €“ Utopie

    Nov 1, 2016, 00:00

  • Cost Effectiveness Analysis of Pirfenidone For The Treatment of Mild To Moderate Idiopathic Pulmonary Fibrosis (IPF) Compared To Best Supportive Care And Nintedanib From The Italian NHS Perspective

    Nov 1, 2016, 00:00

  • The Economic Burden of Hypertension in Latin America

    Nov 1, 2016, 00:00

  • Application of Value of Information Analysis To Minimize Decision Risk In Malaysia

    Nov 1, 2016, 00:00

  • Cost Of Dengue And Cost-Effectiveness Of The Dengue Vaccine In Panama

    Nov 1, 2016, 00:00

  • Association Between Eq-5d And Changes in Asthma Symptoms, Severity, and Qol In Patients With Severe Eosinophilic Asthma

    Nov 1, 2016, 00:00

  • Epidemiology and Costs of Psoriatic Arthritis in Germany – A Retrospective Claims Data Analysis

    Nov 1, 2016, 00:00

  • Evaluating the Effectiveness of Treatments of Opioid use Disorder Based on Recovery Outcomes- How to Bridge the Disconnect Between Clinical Trial Outcomes and Recovery Outcomes?

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Including A Pentavalent (Hib-Hbv-Dtp) Vaccine In The National Childhood Immunization Schedule Of Iran

    Nov 1, 2016, 00:00

  • Evaluating the Relative Effectiveness of Two Malnutrition Risk Assessment Tools in Surgical Population at a Tertiary Care Hospital in Malaysia

    Nov 1, 2016, 00:00

  • The EQ-5D-5L Instrument Demontrates Better Performance Compared With The EQ-5D-3L In Psoriatic Patients

    Nov 1, 2016, 00:00

  • The GM Ahsn Af Landscape Tool- A Shared Data Platform to Identify Health and Economic Opportunities to Reduce Incidence of Stroke Through Effective Anticoagulant Management of Patients with Atrial Fibrillation in Greater Manchester

    Nov 1, 2016, 00:00

  • Valuing Cancer-Related Premature Mortality- A Comparison of Consumer-Led Versus Producer-Led Approaches

    Nov 1, 2016, 00:00

  • Effectiveness of A Referral Program For Early Arthritis Diagnosis At Primary Care Centers In Portugal - Final Results From The Siara Study

    Nov 1, 2016, 00:00

  • A Review of Health State Utility Values Used in UK Nice Appraisals in Advanced NSCLC

    Nov 1, 2016, 00:00

  • Racial/Ethnic Disparity in Individual Economic Burden of Diabetes in the USA

    Nov 1, 2016, 00:00

  • A Health Technology Assessment of Single Balloon Valvuplasty

    Nov 1, 2016, 00:00

  • Pro Instruments Used In Studies Published Since 2005- Which Populations And Diseases Have Had The Most Tools Developed?

    Nov 1, 2016, 00:00

  • The Relationship Between Antenatal Care And Health Facility Delivery

    Nov 1, 2016, 00:00

  • Direct Costs and Healthcare Resource Use Associated with Advanced Non-Small Cell Lung Cancer Management in Previously Treated Patients in Portugal

    Nov 1, 2016, 00:00

  • Patient Focused Technology Enabled Programs Improve Outcomes in Primary Total Hip (THA) Total Knee Arthroplasty (TKA) Patients

    Nov 1, 2016, 00:00

  • Flexibly Modelling HBA1C Progression in Type 2 Diabetes to Estimate the Impact of Clinical Inertia on Costs and Quality Adjusted Life Years

    Nov 1, 2016, 00:00

  • The Effect of Physical Activity on the Mental and Emotional State of University Students

    Nov 1, 2016, 00:00

  • A Population Based Diabetes Drug Utilization Analysis in Chinese Community- A Retrospective Database Study

    Nov 1, 2016, 00:00

  • Safety And Effectiveness of Autologous Platelet Rich Plasma Therapy For Lateral Epicondylitis- Systematic Reviews

    Nov 1, 2016, 00:00

  • Is the Lack of Inclusion on the National Drug Reimbursement List the end of the World for Access?

    Nov 1, 2016, 00:00

  • Unlocking Established Products Patient and Societal Value in Additional Indications

    Nov 1, 2016, 00:00

  • Implementation Of The Insurance Programs For Catastrophic Diseases In China- A Qualitative Study

    Nov 1, 2016, 00:00

  • Budget Impact Analysis Of Secukinumab In Moderate To Severe Plaque Psoriaris, Ankylosing Spondylitis And Psoriatic Arthritis In France

    Nov 1, 2016, 00:00

  • Quantifying Informal Versus Formal Care, and Financial Caregiver Burden, for Stroke Patients in Asia- A Structured Literature Review

    Nov 1, 2016, 00:00

  • Modelling the Effectiveness of Ibrutinib Versus Rituximab-Based Chemotherapy Regimens in Relapsed/Refractory Mantle Cell Lymphoma

    Nov 1, 2016, 00:00

  • Open Versus Endovascular Repair in Patients with Abdominal Aortic Aneurysm in Spain ─ A Cost Comparisson

    Nov 1, 2016, 00:00

  • Disease Burden of Herpes Zoster in Taiwan- A Five-Year Population-Based Study

    Nov 1, 2016, 00:00

  • The Impress (International Multiple Sclerosis) Study; Results On The Socio-Economic Burden, Health Related Quality Of Life And Experience Of Multiple Sclerosis Patients In France

    Nov 1, 2016, 00:00

  • Quality of Life of Patients Treated for Multiple Myeloma (MM) in France in a Real-World Setting

    Nov 1, 2016, 00:00

  • War Rages Between Infliximab Biosimilars and Their Originator

    Nov 1, 2016, 00:00

  • Access To Anti-Infective Medicines For Systemic Use In Armenia

    Nov 1, 2016, 00:00

  • Economic Assessment of Dydrogesterone Compared with Progesterone for the Treatment of Threatened Andhabitual Miscarriage in China

    Nov 1, 2016, 00:00

  • The Burden of Comorbid Allergic Rhinitis and Asthma

    Nov 1, 2016, 00:00

  • Validity and Reliability of Three New Instruments for Parents and Children Assessing Nutrition and Physical Activity Behaviors, Environment and Knowledge and Health in Childhood and Adolescence in Greece During the Economic Recession- Data ...

    Nov 1, 2016, 00:00

  • Kangaroo Mother Care- A Cost Effective and an Alternate Method to Manage Hypothermia in Low Birth Weight Babies for Better Clinical Outcome

    Nov 1, 2016, 00:00

  • Direct Medical Costs Associaed with Diabetic Complicaitons in Patients with Type 2 Diabetes in Us and South Korea

    Nov 1, 2016, 00:00

  • Real-World Evidence of Ruxolitinib In The Treatment of Myelofibrosis- Experince of A Portuguese Hospital Center

    Nov 1, 2016, 00:00

  • Sacubitril/Valsartan Estimated Cost Savings Based on Paradigm-HF Results

    Nov 1, 2016, 00:00

  • Impact Of Patients Counselling On Mindful Attention Awareness And Stress In Cancer Patients

    Nov 1, 2016, 00:00

  • Differences In Pricing Policies For Generic And Biosimilar Medicines

    Nov 1, 2016, 00:00

  • Skeletal-Related Events (SRES) and Renal Function in Patients with Symptomatic Multiple Myeloma (MM)- Results from Belgium, France, Germany, Italy, Spain, Switzerland and The United Kingdom

    Nov 1, 2016, 00:00

  • The Impact of Economic Crisis on Drug Consumption and Pharmaceutical Expenditure in Greece

    Nov 1, 2016, 00:00

  • Evaluation of the Effect of Pharmacogenetic Dosing of Warfarin- Should Non-Randomized Clinical Studies be Considered?

    Nov 1, 2016, 00:00

  • The Incidence of Hypoglycemia in Type II Diabetes Mellitus (T2DM) Patients Treated with Insulin Therapy in Combination with DPP-4 in Greece. A Sub-Analysis of Hypo 2 Study

    Nov 1, 2016, 00:00

  • The Public Acceptance And Willingness-To-Pay (Wtp) Of Dengue Vaccine In Penang, Malaysia- Assessment with A Contingent Valuation Study

    Nov 1, 2016, 00:00

  • Mapping of The Biosimilar Drug Policy in 10 Central Eastern European Countries

    Nov 1, 2016, 00:00

  • Medication Safety Warnings- Awareness, Source and Actions of Consumers in the U.S

    Nov 1, 2016, 00:00

  • Cost-Minimization Analysis of Panitumumab Vs Cetuximab as Monotherapy for Chemo-Refractory Patients with WT KRAS MCRC in Mexico

    Nov 1, 2016, 00:00

  • Risk Share Agreements (RSA), Product Listing Agreements (PLA) or Patient Access Schemes (PAS) - All the Same or Different?

    Nov 1, 2016, 00:00

  • Phase III Trial of Recombinant Human Parathyroid Hormone in Hypoparathyroidism- A Post-HOC Analysis of Change in Health-State Utility Among Responders

    Nov 1, 2016, 00:00

  • The Uk Early Access To Medicines Scheme- A 2-Year Status Update On Successes, Issues And Controversies

    Nov 1, 2016, 00:00

  • Extracting Dosage Per Day From Free-Text Medication Prescriptions

    Nov 1, 2016, 00:00

  • Methodological Review of Survival Models- Application to A Persistence Analysis Based on Long Acting Parenteral Antipsychotic in Retail Pharmacies in France

    Nov 1, 2016, 00:00

  • A Retrospective Study on Association Between Change In Bmi And Incidence Of Hypertension Using A Health Care Database In Japan

    Nov 1, 2016, 00:00

  • Construct Validity Of The 10-Year Time Trade-Off Method In Psoriasis Patients

    Nov 1, 2016, 00:00

  • Day Surgery Vs Regular Admission- Activity-Based Cost Analysis of Percutaneous Transluminal Coronary Angioplasty (PTCA) Procedures From Hospital Perspective

    Nov 1, 2016, 00:00

  • Generating Health Utility Values From US SF-36 Scores For French Assessment- Comparison of 3 Mapping Methods

    Nov 1, 2016, 00:00

  • Payer Requirements in the Treatment of Chronic Heart Failure

    Nov 1, 2016, 00:00

  • Quantifying the Health Economic Value Associated with Unit Changes in HBA1C in Type 1 Diabetes Mellitus

    Nov 1, 2016, 00:00

  • Evaluation of Quality of Pharmacoeconomic Studies in Asia Pacific and Identification of Influencing Variables

    Nov 1, 2016, 00:00

  • Antibiotic Treatment of Uncomplicated Urinary Tract Infection In Women- A Comparative Cost-Effectiveness Study

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Apremilast In Moderate-To-Severe Psoriasis In Canada

    Nov 1, 2016, 00:00

  • The Real-Life Effectiveness and Care Patterns of Diabetes Management Study for Greece. “RECAP-DM”

    Nov 1, 2016, 00:00

  • Utility By Treatment Line In Multiple Myeloma; Analysis of Over 9000 EQ-5Q-3L Questionnaires from the Emmos Registry

    Nov 1, 2016, 00:00

  • Trends of Including Pharmacoeconomics Course in the Undergraduate Pharmacy Curriculum

    Nov 1, 2016, 00:00

  • Changes of The Reimbursement Recommendations Focused on Oncology Drugs Before and after The Implementation of The 2013 Benefit Enhancement Policy in Korea

    Nov 1, 2016, 00:00

  • Productivity Loss of Rheumatoid Arthritis Patients By Their Level Of Disease Activity Score

    Nov 1, 2016, 00:00

  • The Case For Bayesian Methods In Benefit-Risk Assessment- Overview And Future Directions

    Nov 1, 2016, 00:00

  • Safety and Efficacy of High-Potency Statin and Ultra-Low LDL in Chinese Patients with Established Cardiovascular Disease- Practice Impact of the New Cholesterol Guidelines

    Nov 1, 2016, 00:00

  • Adjustment Of OS In Crystal For Post-Study Anti-Cancer Therapies

    Nov 1, 2016, 00:00

  • Knowledge of Blood Pressure Control Programs In University Students

    Nov 1, 2016, 00:00

  • Estimation of Willingness to Pay for a Quality-Adjusted Life Year on a Cure

    Nov 1, 2016, 00:00

  • Australian Influenza National Surveillance Data (2009 to 2014) – Variations by Sex, Age Group, and Influenza Type

    Nov 1, 2016, 00:00

  • Cost Comparison in the Management of the Renal Cell Carcinoma with in Spain- Pazopanib vs. Sunitinib

    Nov 1, 2016, 00:00

  • Identification of Adverse Events In Coronary Artery Disease Patients Based on Health-Related Quality of Life Outcome Data

    Nov 1, 2016, 00:00

  • The Economic Evaluation of Bone-Anchored Hearing AIDS (BAHAS)- A Systematic Literature Review

    Nov 1, 2016, 00:00

  • Absence of Price-Prevalence Correlation in Orphan Drugs in Italy

    Nov 1, 2016, 00:00

  • “Best Supportive Care” or “Therapy According to Physician's Choice” as Appropriate Comparator for German HTA Dossiers – An Underestimated Chance or Risk for the Benefit Assessment?

    Nov 1, 2016, 00:00

  • Frequency of Occurance of Myocardial Infarction in Hungary Between 2004-2012

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Radial Access Versus Femoral for Diagnostic Cardiac Catheterization and Coronary Intervention in Colombia

    Nov 1, 2016, 00:00

  • Reflecting Uncertainty in Early HTA When Evidence on Parameter Distributions is Lacking- A Comparison of Methods

    Nov 1, 2016, 00:00

  • Cost Minimization Analysis Of Tedizolid For The Treatment Of Acute Bacterial Skin And Skin Sub-Structure Infections (Absssi) In Greece

    Nov 1, 2016, 00:00

  • Economic Evaluation of Targeted Therapies in Metastatic Clear Renal Cell Carcinoma in Canada

    Nov 1, 2016, 00:00

  • Improving the System of Healthcare Provision for Patients with Diffuse Toxic Goiter in Ukraine

    Nov 1, 2016, 00:00

  • Knowledge, Attitude and Practice Towards Hepatitis B Among Medical College Students of Quetta, Pakistan

    Nov 1, 2016, 00:00

  • The Prevalence of Atypical Antipsychotic Medication Use For Pediatric Psychosis in Korea

    Nov 1, 2016, 00:00

  • Is utilization of Adjuvant Endocrine Therapy Affected Mainly by Patient Drug Costs? An Analysis of Two Databases

    Nov 1, 2016, 00:00

  • Trends In Outpatient Use Of Antibiotics In Croatia

    Nov 1, 2016, 00:00

  • Antibiotic Utilisation and Expenditure in Ireland

    Nov 1, 2016, 00:00

  • Impact of Whole Exome Sequencing (WES) on Costs and Medical Decision-Making

    Nov 1, 2016, 00:00

  • Manufacturers’ And Pharmacists’ Satisfaction with Different Pharmaceutical Distribution Models in Europe

    Nov 1, 2016, 00:00

  • Analysis of The Costs Associated with Vitamin K Antagonist Treatment for Stroke Prevention in Non Valvular Atrial Fibrialltion in Russia

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of An Automated Medication System Implemented In A Danish Hospital Setting

    Nov 1, 2016, 00:00

  • Policies for Use of Real-World Data in Health Technology Assessment- A Comparative Study of 6 HTA Agencies

    Nov 1, 2016, 00:00

  • Non-Adherence to Antihypertensive Drugs- A Systematic Review and Meta-Analysis

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Analysis of Ixekizumab vs. Secukinumab in Sequential Biologic Treatment of Psoriasis in the UK

    Nov 1, 2016, 00:00

  • Cost of Antihyperglycemic Therapy In Type 2 Diabetes Patients Depending on HBA1C And Bmi Values

    Nov 1, 2016, 00:00

  • Treatment Pattern of Antibiotics and Cost Analysis in Sepsis Patients- A Cross Sectional Retrospective Prospective Study

    Nov 1, 2016, 00:00

  • Utilization Of Physiotherapy Visits Completed In Specialized Home Care In Hungary Between 2010 And 2014

    Nov 1, 2016, 00:00

  • Quality Of Life and Economic Impact Of Neuropathic Pain and Fibromyalgia Syndrome In Chronic Back Pain Patients In Tertiary Care

    Nov 1, 2016, 00:00

  • How Well is Warfarin Controlled In Real World Clinical Practice in Hong Kong?

    Nov 1, 2016, 00:00

  • Avoidable Hospitalizations Through Effective Primary Care At A Pediatric Hospital In The Colombian Caribbean

    Nov 1, 2016, 00:00

  • Economic Modeling of Risk-Adapted Screen-and-Treat Strategies in Women at High-Risk for Breast or Ovarian Cancer

    Nov 1, 2016, 00:00

  • Health Care Costs Among COPD Patients Are Doubled Compared to A Control Population

    Nov 1, 2016, 00:00

  • Resource use in Chronic Heart Failure in the UK- A Systematic Review

    Nov 1, 2016, 00:00

  • Long-Term Visual Functioning Improvement is Associated with Resolution of Vitreomacular Adhesion in Subjects with Vitreomacular Traction, Including Macular Hole Treated with Intravitreal Ocriplasmin- Results From The Oasis Study

    Nov 1, 2016, 00:00

  • Accounting for the Imperfect External Validity of Discrete Choice Experiments When Predicting Demand

    Nov 1, 2016, 00:00

  • Optimal Design of Pre-Authorization Trials for Effectiveness Evaluation in Severe Asthma

    Nov 1, 2016, 00:00

  • A Retrospective, Cross Sectional Study on The Prevalence of Hyperuricemia Using A Healthcare Database In Japan

    Nov 1, 2016, 00:00

  • Availability And Costs Of Pediatric Formulations In India - A Case Study

    Nov 1, 2016, 00:00

  • Feasibility of Electronic Medical Records in Australia, China, and Japan to Support Novelty (A Novel Observational Longitudinal Study of Patients with Asthma and/or COPD)

    Nov 1, 2016, 00:00

  • Rare and Intractable Disease Policy Reform in Japan- A Before and After Analysis

    Nov 1, 2016, 00:00

  • Effects of The Mental Health Parity and Addictions Equality Act on Depression Treatment Choice in Primary Care Facilities in The United States

    Nov 1, 2016, 00:00

  • Cost-Related Medication Nonadherence Among Elderly Medicare Cancer Survivors Using Erythropoiesis-Stimulating Agents

    Nov 1, 2016, 00:00

  • The Direct Cost Components in Heart Failure with Preserved Ejection Fraction (HF-PEF) in Turkey- The Results of A Delphi Panel

    Nov 1, 2016, 00:00

  • Annual Cost Аnalysis for Medicinal Products for Rare Diseases in Bulgaria

    Nov 1, 2016, 00:00

  • Patient Preferences Versus Physician Perceptions Of Treatment Decisions In Advance Stage Prostate Cancer

    Nov 1, 2016, 00:00

  • Cost-Efficiency Of Clinical Pharmacy Services At Ministry Of Health In Saudi Arabia Application Of American Model

    Nov 1, 2016, 00:00

  • Economic Evaluation Of Abbvie’s Regimen (Viekirax/Exviera) For Patients With Genotype 1b Hcv In Greece

    Nov 1, 2016, 00:00

  • Swedish Perspective on Health Technology Assessments with Incrementally Lower Costs and Effects

    Nov 1, 2016, 00:00

  • Cost-Utility Analysis of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure in Greece

    Nov 1, 2016, 00:00

  • Use Of Electronic Health Information Systems (Ehis) By Healthcare Professionals (Hcps) And The Perception Of Its Value In Reducing Medication Risks And Safety For Patients

    Nov 1, 2016, 00:00

  • The Clinical and Economic Impact of School-Based Quadrivalent Human Papillomavirus Vaccine on Female or Both Genders in Singapore

    Nov 1, 2016, 00:00

  • Impact of Hypoglycaemic Events on Healthcare Resource Use in Type 2 Diabetes Patients

    Nov 1, 2016, 00:00

  • Impact of Community Care Subsidies on Care Use Of Elderly People

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Screening for Severe Sleep-Disordered Breathing in Japan

    Nov 1, 2016, 00:00

  • Systematic Review of Cost-Effectiveness Models in Diabetes for Insulin Analogues

    Nov 1, 2016, 00:00

  • Longitudinal Trajectories of Depressive and Anxious Symptoms Following a Self-Management Intervention for Haemodialysis Patients

    Nov 1, 2016, 00:00

  • The Economic Impact of Schizophrenia from an English NHS Perspective Based on Estimates from Electronic and Self-Reported Methods of Data Collection

    Nov 1, 2016, 00:00

  • How are Adverse Effects Incorporated in Cost-Effectiveness Models? A Study of Current Practice in Oncology Studies Submitted to HAS

    Nov 1, 2016, 00:00

  • The Indirect Costs of Breast Cancer in The Slovak Republic

    Nov 1, 2016, 00:00

  • A Systematic Literature Review of Cysteamine Bitartrate Preparations in Patients with Cystinosis

    Nov 1, 2016, 00:00

  • Time to Diabetes Related Complications for Newly Diagnosed Diabetes Patients in Singapore

    Nov 1, 2016, 00:00

  • Pharmacoeconomic Assessment of Nintedanib For The Treatment of Idiopathic Pulmonary Fibrosis In The Greek Healthcare System

    Nov 1, 2016, 00:00

  • Modeling Treatments and Outcomes in Metastatic Castration-Resistant Prostate Cancer- A Case Study of Discrete Event Simulation and the Challenges for A UK Nice Evaluation

    Nov 1, 2016, 00:00

  • Use of Sutureless Prosthesis Neutralizes Expected Worse Economic Impact of High Risk Patients Undergoing Aortic Valve Replacement

    Nov 1, 2016, 00:00

  • Economic Burden of Ankylosing Spondylitis In Europe. A Systematic Review of The Literature

    Nov 1, 2016, 00:00

  • Systematic Review of the Value of Safety-Engineered Devices in Reducing Needlestick and Sharps Injuries

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Biphasic Insulin Aspart 50 Versus Biphasic Human Insulin 50 in People with Type 2 Diabetes Mellitus in China

    Nov 1, 2016, 00:00

  • The Role of Weight Loss or Gain In Payer Assessment of Diabetes Drugs

    Nov 1, 2016, 00:00

  • A Restrospective Non-Interventional Study Among Patients with Relapsing Multiple Sclerosis Switching to Fingolimod or to Other Disease Modifying Therapies

    Nov 1, 2016, 00:00

  • Social And Economic Value of Portuguese Community Pharmacies In Public Health

    Nov 1, 2016, 00:00

  • Universal Mass Vaccination With Phid-Cv Is Cost-Effective In Croatia

    Nov 1, 2016, 00:00

  • Comparison of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (Esmo-Mcsb) and the American Society of Clinical Oncology (Asco) Framework for Assessing Value in Cancer Care

    Nov 1, 2016, 00:00

  • Status and Expenses- Re-Use Of Insulin Syringe Needles in the Diabetic Patients in Beijing

    Nov 1, 2016, 00:00

  • Evaluating the Cost-Effectiveness of Liraglutide 1.8Mg Versus Lixisenatide 20μg for Patients with Type 2 Diabetes Mellitus in the UK Setting

    Nov 1, 2016, 00:00

  • A Retrospective Premier Database Study to Evaluate Differences Between Progel™ Pleural Air Leak Sealant As Compared with Other Sealants in The Inpatient Surgical Setting

    Nov 1, 2016, 00:00

  • Treatment Gap of Post Osteoporotic Fractures in Taiwan- A Nationwide Cohort Study, 2008-2013

    Nov 1, 2016, 00:00

  • Prevalence and Patient Characteristics of Multiple Sclerosis (Ms) in Japan

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Incobotulinumtoxin-A With Flexible Treatment Intervals Compared To Fixed Treatment Intervals In The Management Of Blepharospasm And Cervical Dystonia

    Nov 1, 2016, 00:00

  • Markov Models For Health Economic Evaluation Modelling In R With The Heemod Package

    Nov 1, 2016, 00:00

  • Antimicrobial Agents Dispensing In Upper Respiratory Tract, Gastrointestinal Tract Infections And Infected Wound In Thai Drug Stores In 2015

    Nov 1, 2016, 00:00

  • Stock Reduction of Erythropoietin for Patients on Hemodialysis at Somdech Phra Debaratana Medical Center

    Nov 1, 2016, 00:00

  • Cost-Effectiveness of Long Acting Granulocyte Colony–Stimulating Factor for Primary Prophylaxis of Febrile Neutropenia in Breast Cancer in The Russia

    Nov 1, 2016, 00:00

  • Mapping of Existing Data Sources for the Conduct of Real-World Studies on Lung Cancer in China

    Nov 1, 2016, 00:00

  • Healthcare Costs of Inflammatory Bowel Disease in The Biologic Era- A Study Of 2,451 Patients with Twelve years Follow-Up Evaluation

    Nov 1, 2016, 00:00

  • The assessment of advanced medicinal products (atmp) in germany- is the practice to define atmp drugs as procedures in compliance with european legislation?

    Nov 1, 2016, 00:00

  • Cost - Effectiveness Analysis of Presepsin Compared with C-Reactive Protein and Procalcitonin in Detecting Severe Bacterial Infection in Children Aged 29 Days to 36 Months Old with Fever Without Source

    Nov 1, 2016, 00:00

  • Towards Improved Cervical Cancer Primary Screening in Austria - A Decision-Analytic Benefit-Harm Analysis

    Nov 1, 2016, 00:00

  • Quality of Life of Patients with Alzheimer's Disease - A Comparison with General Population

    Nov 1, 2016, 00:00

  • Early Payer Scientific Advice Procedures In The Eu- Which One Is Most Suited For Pharmaceutical Compaines?

    Nov 1, 2016, 00:00

  • Cost-Effectiveness Of Prevenar 13 In Children In Portugal

    Nov 1, 2016, 00:00

  • Assessment of Criteria Influences on Judicious Selection of New Drug for Future Coverage Policy in Iran- An Analysis with Structural Equation Modeling

    Nov 1, 2016, 00:00

  • Translation of the DN4 (Douleur Neuropathique EN 4 Questions) INTO 85 Languages- Challenges and Importance of the Conceptual Defintion of the Original Version

    Nov 1, 2016, 00:00

  • Comparative Effectiveness of Brand-Name and Generic Warfarin on Stroke and Bleeding Events in Atrial Fibrillation Patients- A 6-Year Population-Based Retrospective Cohort Study in Taiwan

    Nov 1, 2016, 00:00

  • The Impact of Regional Cost-Saving Initiatives on the Uptake of Antiretroviral Drugs in London

    Nov 1, 2016, 00:00

  • Indirect Treatment Comparison of Ustekinumab Versus Other Biologics In Moderate To Severe Crohn’s Disease- A 1-Year Treatment Sequence Analysis

    Nov 1, 2016, 00:00
  • «
  • 71
  • 72
  • 73
  • 74
  • 75 (current)
  • 76
  • 77
  • 78
  • 79
  • 80
  • »